Overview
This workshop is designed for QPPVs, whether based in the UK or EU, and UK National Contact Persons for PV to meet and share experiences and best practices across a range of type and size of companies, and also to hear the perspective from the MHRA.
This year we are having a special online edition where we tackle PV questions related to the Windsor Framework, together with the participation of MHRA. This meeting is design for/intended to support industry with the implementation/preparation for the Windsor Framework and to answer outstanding industry questions.
During the webinar, we will have two dedicated moments to address participant questions:
- MHRA will respond to questions that have been pre-submitted through this survey, ensuring thorough preparation for discussions and addressing inquiries.
- Participants can also ask questions during an open session using Slido. Please ensure you refer to the MHRA Website for any updates before submitting questions.
|
Got questions for the MHRA? Don’t miss out—submit yours in advance here! |
Program Committee
-
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Sophie Radicke, MSc Head of GPvP and Senior Pharmacovigilance Inspector
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Louise Woodward, PhD UK QPPV and Local Safety Responsible
Roche Products Ltd, United Kingdom -
Helen Fiddes Head of Country Pharmacovigilance, UK and Ireland
Bristol-Myers Squibb, United Kingdom -
Lauren East Head, Pharmacovigilance UK
Abbvie, United Kingdom -
Claudia Ferreira Scientific Programs Manager
DIA, Switzerland
Have an account?